These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts. Cooper M; Lindholm P; Pieper G; Seibel R; Moore G; Nakanishi A; Dembny K; Komorowski R; Johnson C; Adams M; Roza A Transplantation; 1998 Oct; 66(7):838-44. PubMed ID: 9798691 [TBL] [Abstract][Full Text] [Related]
43. Effect of cyclosporine on distribution of macrophage subpopulations in rat hepatic allograft. Yamaguchi Y; Misumi M; Mori K; Takata N; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Takeya M Dig Dis Sci; 1993 Apr; 38(4):619-25. PubMed ID: 8462362 [TBL] [Abstract][Full Text] [Related]
44. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats. Harrison PC; Madwed JB J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890 [TBL] [Abstract][Full Text] [Related]
45. Expression of stress proteins and lymphocyte reactivity in heterotopic cardiac allografts undergoing cellular rejection. Qian J; Moliterno R; Donovan-Peluso MA; Liu K; Suzow J; Valdivia L; Pan F; Duquesnoy RJ Transpl Immunol; 1995 Jun; 3(2):114-23. PubMed ID: 7582902 [TBL] [Abstract][Full Text] [Related]
46. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK; Lemström KB; Häyry PJ Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [TBL] [Abstract][Full Text] [Related]
47. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection. Cai B; Roy DK; Sciacca R; Michler RE; Cannon PJ Int J Cardiol; 1995 Jul; 50(3):243-51. PubMed ID: 8537148 [TBL] [Abstract][Full Text] [Related]
48. Improved methods for transplanting split-heart neonatal cardiac grafts into the ear pinna of mice and rats. Fey TA; Krause RA; Hsieh GC; Andrews JM; Bretheim PT; Morgan SJ; Luly JR; Mollison KW J Pharmacol Toxicol Methods; 1998 Feb; 39(1):9-17. PubMed ID: 9596143 [TBL] [Abstract][Full Text] [Related]
49. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337 [TBL] [Abstract][Full Text] [Related]
50. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection. Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952 [TBL] [Abstract][Full Text] [Related]
51. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303 [TBL] [Abstract][Full Text] [Related]
52. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Smith CR; Mohanakumar T; Shimizu Y; Yu S; Otomo N; Kaleem Z; Flye MW Transplantation; 2000 Jan; 69(2):294-9. PubMed ID: 10670641 [TBL] [Abstract][Full Text] [Related]
53. [Inhibition of acute rejection of heart graft in rats without immunosuppressants after intrathymic myocardial cell inoculation in the neonatal period]. Seo K; Imai Y; Imamura S; Ohta Y; Nishikawa T; Matsuoka R; Hiroe M Kyobu Geka; 1992 Nov; 45(12):1067-70. PubMed ID: 1405124 [TBL] [Abstract][Full Text] [Related]
54. Monitoring the bioenergetics of cardiac allograft rejection using in vivo P-31 nuclear magnetic resonance spectroscopy. Canby RC; Evanochko WT; Barrett LV; Kirklin JK; McGiffin DC; Sakai TT; Brown ME; Foster RE; Reeves RC; Pohost GM J Am Coll Cardiol; 1987 May; 9(5):1067-74. PubMed ID: 3553275 [TBL] [Abstract][Full Text] [Related]
55. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat. Lin H; Chensue SW; Strieter RM; Remick DG; Gallagher KP; Bolling SF; Kunkel SL J Heart Lung Transplant; 1992; 11(2 Pt 1):330-5. PubMed ID: 1576139 [TBL] [Abstract][Full Text] [Related]
56. Rejection pattern of cardiac and skeletal muscle allografts: implications for surveillance of cardiac rejection. Benedetti E; Blanchard J; Sekosan M; Raofi V; Dunn T; Lutrin F; Massad M Transplant Proc; 1998 Aug; 30(5):1929. PubMed ID: 9723338 [No Abstract] [Full Text] [Related]
57. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents. Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099 [TBL] [Abstract][Full Text] [Related]
58. Cellular mechanisms underlying differential rejection of sequential heart and lung allografts in rats. Moller F; Hoyt G; Farfan F; Starnes VA; Clayberger C Transplantation; 1993 Mar; 55(3):650-5. PubMed ID: 8456486 [TBL] [Abstract][Full Text] [Related]